DOI: 10.1002/ ms3.794
ORIGINAL ARTICLE
The mo esis an Newcas le disease accine e ec i ely
p o ec s SPF, na i e, and comme cial chickens in
challenge wi h i ulen i us
Mohammad Abdoshah1Mohammad Hassanzadeh2Shahin Masoudi1
Abbas Ash a i1Ali Reza Youse i1Minoo Pa o i Nas 3
1Ag icul u al Resea ch, Educa ion and
Ex ension O ganiza ion (AREEO), Razi Vaccine
and Se um Resea ch Ins i u e, Ka aj, I an
2Depa men o Poul y Diseases, Facul y o
Ve e ina y Medicine, Uni e si y o Teh an,
Teh an, I an
3Depa men o Molecula Diagnosis, Mabna
Ve e ina y Lab, Ka aj, I an
Co espondence
Mohammad Abdoshah, Razi Vaccine and
Se um Resea ch Ins i u e, Ag icul u al
Resea ch, Educa ion and Ex ension
O ganiza ion (AREEO), Ka aj, I an.
Email: [email p o ec ed],
[email p o ec ed]
Funding in o ma ion
Razi Vaccine and Se um Resea ch Ins i u e,
G an /Awa d Numbe :
12-18-18-036-95017-950501
Abs ac
Backg ound: Due o he mo e s abili y and a be e homogeneci y in immune esponse,
he use o he mo esis an accines in di e en chicken ypes has been inc eased.
Objec i e: This s udy aimed o e alua e he e icacy o a newly de eloped Newcas le
disease accine (ND.TR.IR) o igina ing om I-2 s ain in speci ic pa hogen- ee (SPF)
and na i e and b oile chickens.
Me hods: Following de e mina ion o pa hogenici y indices on he candida e seed,
h ee e icacy examina ions we e conduc ed. In he i s expe imen , 120 1-day-
old SPF chickens we e andomly alloca ed o six g oups and ei he accina ed wi h
ND.TR.IR ia eye d op a 1, 7, and 21 days o age (V1,V
7,andV
21), o conside ed as non-
accina ed con ol g oups (C1,C
7,andC
21). A 20 h pos - accina ion day, se a hemag-
glu ina ion inhibi ion (HI) an ibody i es agains ND i us (NDV) we e measu ed and
hen he chickens we e challenged by i ulen NDV ( NDV). In he second and hi d
expe imen s, he e icacy o ND.TR.IR accine was compa ed o ou ine accina ion
p og am (B1 and LaSo a) in na i e and b oile chickens ha we e accina ed a 10 and
20 days o age, espec i ely. The HI an ibody i es we e measu ed on 10, 20, 30, and
40 days o age, and also challenge e icacy es wi h NDV was conduc ed on 30 days
o age.
Resul s: The s udied i us, as a accinal seed, complied wi h he pa hogenici y indices
o a i ulen NDV and molecula iden i y o I-2 s ain. In he e icacy e alua ion i-
als, he accina ed chickens had highe HI an ibody i es agains NDV compa ed wi h
hei co esponding con ol chickens (p<0.05). Resul s o he challenge es s indica ed
95% and 100% p o ec ion agains NDV in na i e, SPF, and b oile - accina ed chick-
ens, espec i ely.
Conclusions: The p esen indings indica ed ha adminis a ion o ND.TR.IR induced
app op ia e HI an ibody i es agains NDV in SPF, na i e, and b oile chickens associ-
a ed wi h good p o ec ion in e icacy es .
This is an open access a icle unde he e ms o he C ea i e Commons A ibu ion-NonComme cial-NoDe i s License, which pe mi s use and dis ibu ion in any
medium, p o ided he o iginal wo k is p ope ly ci ed, he use is non-comme cial and no modi ica ions o adap a ions a e made.
© 2022 The Au ho s. Ve e ina y Medicine and Science published by John Wiley & Sons L d.
Ve Med Sci. 2022;8:1539–1546. wileyonlinelib a y.com/jou nal/ ms3 1539
1540 ABDOSHAH ET AL.
KEYWORDS
chicken, e icacy, Newcas le disease, he mo esis an , accine
1INTRODUCTION
Newcas le disease (ND), a highly con agious and widesp ead poul y
disease, is an unde lying con ibu o o economic loss in comme cial
and backya d poul y locks (Lawal e al., 2016). The u al poul y a ms
play a pi o al ole in ood chain supply in de eloping coun ies; how-
e e , hey ha e o en been a ec ed by in ec ious diseases such as ND,
occu ing by a ian pa amyxo i us-1 (Ka enbel e al., 2006; Shahid
Yousa zai & Liaqua -Ahmad, 2017). Res ic ion o i ulen ND i uses
( NDV) ci cula ion in he backya d chickens could dec ease he isk o
he i us ansmission o comme cial a ms (Adwa & Lukeso a, 2008).
Vaccina ion agains ND is he mos easible and p o ec i e p e en ion
app oach agains ND ou b eaks since he 1940s (Dias e al., 2001).
Because o a ela i ely high cos and equi ing long imes o induce
immuni y, as well as he need o be injec ed by ained people, he use
o inac i a ed ND accines is limi ed in illage locks. The ou ine li e
accines (B1 and LaSo a) a e cheape and easie o adminis a e, which
ha e made hem mo e accep able o be adminis a ed in u al condi-
ions. Ne e heless, main enance o he cold chain o li e accines is
he main conce n o achie e e ec i e ND accina ion in a away a eas
(Ahle s e al., 1999; Adwa & Lukeso a, 2008).
In de eloping coun ies, complying wi h s anda d s o age and cold
chain a e somehow di icul ha esul ed in a conside able educ ion o
accine e icacy. App oxima ely, a 2-h imeline o adminis a ion o he
dissol ed and p epa ed common ND accines is ega ded as a majo
limi a ion on hei adminis a ion in u al locks. Al hough lyophiliza-
ion and s abilizing excipien s ha e con e ed ma ginal s abili y on
many accines, he lack o accines ha possess adequa e he mos a-
bili y is o en a p ima y ba ie o global accina ion e o s (Rex oad
e al., 2002).
Unde inapp op ia e condi ions o he cold chain, adminis a ion o
a he mo esis an ND accine could be he p ima y s a egy (Adwa &
Lukeso a, 2008). Se e al he mo esis ance i uses d i en om I-2 o
HR-V4 s ains ha e been in oduced o manu ac u e ND li e accines
(Adwa & Lukeso a, 2008). I has been shown ha he e icacy o hea -
esis an ND accines is kep up o 2 mon hs a 9–29◦C, and 2 weeks a
30–37◦C (Alde s, 2014). In his ega d, p e ious in es iga ions (Fen ie
e al., 2014; Hassanzadeh e al., 2020; Nasse e al., 2000; Van Bo en
e al., 2008) also showed a high p o ec ion agains NDV in chickens
accina ed by I-2.
The e a e many illage chickens and o he backya d poul y ha
a e also po en ial ese oi s o h ea ening o comme cial a ms o
NDV (Hassanzadeh & Bozo gme i Fa d, 2004). In his ega d, he p e-
en ion o ND occu ence a illage locks is a c ucial s ep in main e-
nance sus ainable ag icul u e and con ol o ND ou b eaks in he poul-
y indus y. Mos o he in es iga ions on he mos able ND accines
ha e ocused on hei usage in u al locks; howe e , hei e icacy on
comme cial chickens is a ely s udied. The e o e, his s udy was aimed
o e alua e he e icacy o a de eloping Newcas le disease I-2 accine
(ND.TR.IR) agains ND in speci ic pa hogen- ee (SPF) and na i e chick-
ens as well as comme cial b oile s.
2MATERIALS AND METHODS
2.1 Molecula iden i ica ion o accinal i us
and bioin o ma ics analysis
A iplica e molecula analysis o he F gene sequences and hei co -
esponding amino acids we e ca ied ou o de e mine he iden i y
o he i us. Vi us RNA was ex ac ed using a high pu e i al Nucleic
Acid ki (Roche, Ge many) acco ding o he manu ac u e ’s ins uc-
ions. The ex ac ed RNA was used o syn hesize cDNA using he
Re e Aid RT Re e se T ansc ip ion Ki (The mo Fishe Scien i ic).
An 840 bp segmen o he F gene sequence including clea age si e
was ampli ied using o wa d, 3′-CATCTTCTACCAGGATCCA-5′,and
e e se, 3′-CCAAGAGTTGAGTCTGTGAGTC-5′p ime s (F ozandeh-
Moghadam e al., 2009). Polyme ase chain eac ion (PCR) was pe -
o med using a 5 µl cDNA aliquo in 50 µ; inal olume, including 10 µl
PCR bu e (10X) consis ing o 1.5 mM MgCl2,1µl 10 mM dNTPs, 1 µl
o 10 pM o each p ime , 1 µl (2 U) Taq DNA polyme ase, and 31 µl
double dis illed wa e . Following ini ial dena u a ion a 94◦C o 4 min,
35 cycles including dena u a ion a 94◦C o 60 s, annealing a 50◦C o
60 s, and ex ension a 72◦C o 8 s we e pe o med using a s anda d
he mocycle (Eppendo -Ne hele -Hinz GmbH, 5331). The amplicon
was hen elec opho esed in 1% low mel ing poin aga ose and isual-
ized unde UV ligh using a ansillumina o (bios ep.de, GmbH). The e-
a e , he 840 pb bands we e sliced and pu i ied using a high pu e PCR
p oduc pu i ica ion ki (Roche) and sequenced using he PCR p ime s
and Com o Read me hod (Bionee Co., Ko ea).
The nucleo ide sequences we e edi ed and immed and hen we e
ansla ed o F p o ein amino acid sequence o he i us. The amino
acid sequences we e hen aligned and compa ed wi h comme cial ac-
cinal (B1, LaSo a and i s clone, VG/GA, V4, I-2) and s anda d NDV
(Roakin, He s33) s ains using BioEdi V7.0.0 so wa e. A phylogene ic
analysis was also ca ied ou o iden i y e olu iona y ela ionships
among he s udied i us and some i ulen and accinal NDV s ains
using MEGA 6.0 so wa e wi h Neighbou -Joining algo i hm and 1000
Boo s aps (Figu e 1).
2.2 Pa hogenici y indices
To measu e pa hogenici y indices, esh in ec i e allan oamnionic luid
(AAF) wi h haemagglu ina ion (HA) i e >24was dilu ed in s e ile no -
mal saline (W. H. Allan e al., 1978). The in ace eb al pa hogenici y
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License
ABDOSHAH ET AL.1541
FIGURE 1 The phylogene ic analysis o he ND.TR.IR F-gene and some comme cial accines (B1, LaSo a and i s clone, VG/GA, V4, I-2) and
s anda d i ulen Newcas le disease i us ( NDV) (Roakin, He s33) s ains da ase s, in e ed using he Neighbou -Joining me hod
index (ICPI) was de e mined ia in ace eb al injec ion o 0.05 ml
o he dilu ed i us in o each o 10 1-day-old SPF chickens. The
chickens we e daily e alua ed o gene al and clinical signs o ND,
du ing he nex 8 days and sco ed as ollow: 0 o no mal, 1 o
sick, and 2 o dead chickens. The ICPI was calcula ed as he mean
sco e/chicken/obse a ion o e he examina ion pe iod. The in a-
enous pa hogenici y index (IVPI) was de e mined by in a enous
injec ion o 0.1 ml o he dilu ed i us in o 10 6-week-old SPF chickens.
Chickens we e daily obse ed o gene al and local clinical signs du ing
he nex 10 days and sco ed a each obse a ion. The sco e ze o was
ega ded o no mal, 1 o sick, 2 o pa alyzed, and 3 o dead chick-
ens. The IVPI was calcula ed as he mean sco e pe bi d pe obse a-
ion o e he 10 days (W. H. Allan e al., 1978). Mean emb yo dea h ime
(MDT) was de e mined h ough inocula ion o 0.1 ml o eshly dilu ed
i us om each dilu ion anged 10−6–10−9in o he allan oic ca i y o
i e 9- o 10-days-old emb yona ed SPF chicken eggs a 8:00 AM, and
incuba ion a 37◦C. The emaining i us dilu ions we e kep a 4◦C.
Simila ly, 0.1 ml o each dilu ion was inocula ed in o ano he i e eggs
a 5:00 PM and incuba ed a 37◦C. All he incuba ed eggs we e exam-
ined wice each day o eco d imes o any emb yo dea hs du ing he
nex 7 days. The minimum le hal dosage was de e mined as he highes
i us dilu ion in which all o he inocula ed emb yos died. The MDT was
calcula ed as he mean ime in hou s o he minimum le hal dose o kill
emb yos (W. H. Allan e al., 1978).
2.3 Se ological and challenge e icacy es s
The e icacy o he ND.TR.IR was e alua ed h ough h ee sepa a e
expe imen s in SPF, comme cial b oile and backya d chickens. All he
challenge es s we e unde aken by in amuscula injec ion o ≥105
LD50 o a NDV (He s33) a biosa e y le el 3 in BioFlex B40 Rigid
Body Poul y Isola o (Bell Isola ion Sys ems L d, UK).
2.3.1 E icacy e alua ion in SPF chicken
A o al o 120 newly ha ched SPF chickens we e andomly alloca ed
o h ee accina ed(V1,V7,andV21)and h eecon ol(C
1,C
7,and
C21) g oups (20 chickens/g oup). The accina ed chickens we e inocu-
la ed wi h ≤106EID50 o he accinal i us (ND.TR.IR) h ough he eye
d op a 1 (V1), 7 (V7), and 21 (V21) days o age. Meanwhile, he con-
ols chickens ecei ed dis illed wa e by eye d op. Twen y days a e
each accina ion ime, all o he accina ed and non- accina ed chick-
ens we e challenged. Blood samples we e aken om he expe imen-
al g oups o measu e hemagglu ina ion inhibi ion (HI) an ibody i es
agains NDV immedia ely be o e he challenge es . Du ing he nex
10 days, daily mo ali y was eco ded, and he su i ed chickens we e
con olled o gene al clinical signs o ND (OIE, 2012).
2.3.2 E icacy e alua ion in na i e chicken
A o al o 320 1-day-old na i e chickens we e ea ed du ing 50 days o
he expe imen al pe iod. Ma e nally de i ed an ibody (MDA) agains
NDV was de e mined on 20 andomly selec ed chickens on 1 and
10 days o age (10 chickens/sampling imes). The sampled chickens
we e emo ed om he ial, and he emaining chickens we e an-
domly allo ed in o h ee expe imen al g oups (100 chickens/g oup)
including B1+LaSo a g oup: inocula ion o comme cial B1 and LaSo a
accines, a 10 and 20 days o age, espec i ely; ND.TR.IR g oup: inocu-
la ion o ND.TR.IR accine a 10 and 20 days o age and Con ol g oup:
no accine adminis a ion. Vaccine inocula ion a 10 and 20 days o age
was conduc ed h ough eye d op and d inking wa e , espec i ely. To
measu e HI an ibody i es agains NDV, blood samples we e collec ed
(10 chickens/g oup) a 20, 30, and 40 days o age. On day 30 o age,
20 chickens pe g oup we e ans e ed o isola o s and challenged.
[Co ec ion added on 8 Ap il 2022, a e i s online publica ion: “10
chickens” was co ec ed o “20 chickens” in he p eceding sen ence]
Du ing he nex 10 days, daily mo ali y was eco ded, and he su i ed
chickens we e checked o gene al clinical signs o ND.
2.3.3 E icacy e alua ion in b oile chicken
To e alua e he e icacy o ND.TR.IR in b oile chickens, a o al o 470
1-day-old Ross 308 b oile chickens (20 chickens o de e mining MDA,
and 450 expe imen al chickens [n=150 chickens /g oup]) we e ea ed
unde s anda d en i onmen al and nu i ional condi ions acco ding
o Ross B oile Managemen Handbook. Excep o he numbe o
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License
1542 ABDOSHAH ET AL.
FIGURE 2 Compa ison o he amino acid sequence deduced om he F-gene nucleo ide sequence o ND.TR.IR i us wi h se e al comme cial
accinal (B1, LaSo a and i s clone, VG/GA, V4, I-2) i uses and i ulen Newcas le disease i us ( NDV) (Roakin, He s33) s ains da ase s. The
ND.TR.IR amino acid sequence is accessible unde AHH29550.1. No e: he mo i s loca ed in he box ep esen ing ND.TR.IR and o he NDVs
F-p o ein clea age si e
challenged chickens which was 10 pe g oup, all o he p ocedu es we e
as same as Sec ion 2.3.2 (OIE, 2012).
2.4 Da a analysis
Da a ob ained om se a HI an ibody i es we e s a is ically analyzed
using a gene alized linea model (GLM) p ocedu e o SAS, 9.4 (SAS,
2004). Be o e he analysis, he no mal dis ibu ion o he da a was
es ed by he Shapi o–Wilk es and UNIVARIATE p ocedu e. Mo al-
i y a e, as bina y dis ibu ed da a, was analyzed by GENMOD p oce-
du e using a logi odds a io link unc ion. The ma hema ical model was
as ollows: Yij =µ+Ti+eij whe e Yij is obse a ions, Tiis a ea men
e ec , and eij is esidual andom e o . Resul s we e epo ed as mean
±s anda d e o (SE). Tukey’s es was used o mul iple compa isons,
and s a is ical di e ences we e decla ed a p<0.05.
3RESULTS
3.1 Vi us iden i y
Phylogene ic analysis was based on usion (F) p o ein gene o ND.TR.IR
i us, and some comme cial accines and s anda d NDV s ains a e
ep esen ed in Figu e 1. The sequence analysis demons a ed a com-
ple e iden i y (100%) be ween ND.TR.IR and I-2 s ain, esul ing in dis-
ibu ion a he same clus e . The F gene nucleo ide sequence o he
s udied i us is a ailable a NCBI gene bank as ND.TR.IR unde he
accession numbe KF805771.1.
Amino acid sequence compa ison o he s udied i us wi h some
comme cial accinal i us and s anda d NDV s ains is shown in
Figu e 2. The s udied i us showed a comple e consis ency wi h I-2
s ain, while i had conside able F-p o ein amino acid sequence di e -
ences compa ed o o he NDV s ains. The p o eoly ic clea age si e o
ND.TR.IR is cha ac e ized by h ee basic amino acids a he ca boxy
e minus o F2 and leucine a he amino e minus o F1 (112R-K-Q-
G-R*L117) associa ed wi h he a i ulen NDVs. [Co ec ion added on
8 Ap il 2022, a e i s online publica ion: “ i e basic amino acids” was
co ec ed o “ h ee basic amino acids” in he p eceding sen ence]
TABLE 1 In i o pa hogenici y indices o ND.TR.IR and
speci ica ions o accinal Newcas le disease i us (NDV) s ains
Pa hogenici y indices S anda d accep able alue*Resul
ICPI <0.5 0.0
IVPI 0.0 0.0
MDT (h) >90 138
Abb e ia ions: ICPI, in ace eb al pa hogenici y index; IVPI, in a enous
pa hogenici y index; MDT, mean dea h ime.
*Values ep esen ing speci ica ions o accinal NDV s ains.
3.2 Pa hogenici y indices
Resul s o con en ional in i o pa hogenici y es s and speci ica ions
o accinal NDV s ains a e p esen ed in Table 1. Bo h ICPI and IVPI
alues measu ed o ND.TR.IR we e ze o. The mean dea h ime (MDT)
was 138 h.
3.3 Se ological and challenge e icacy esul s
An ibody i es agains NDV in SPF chickens ha we e inocu-
la ed wi h ND.TR.IR a e shown in Figu e 3. Vaccina ion inc eased
mean HI an ibody i es in V1, V7, and V21 g oups compa ed o
hei co esponding con ol g oups (p<0.05). I is wo h no -
ing ha accina ion in elde chickens caused highe an ibody i es
han ha o younge s (p<0.05). Resul s o he challenge es
showed ha ND.TR.IR adminis a ion caused 100% p o ec ion in
he accina ed chickens compa ed o hei co esponding con ol
chickens.
Mean HI an ibody i es agains NDV in na i e chickens immunized
ia B1 and Laso a o ND.TR.IR accines a e ep esen ed in Figu e 4.
The B1+LaSo a and ND.TR.IR g oups had no signi ican di e ence du -
ing he expe imen al pe iod; howe e , hey had highe HI an ibody
i es compa ed o he con ol chickens (p<0.05). The MDA i e was
dec eased om i s (7.2 ±0.24) o en h (5.6 ±0.26) days o he expe -
imen . The dec easing end in MDAwas con inued in he con ol g oup
and eached 2.7 ±0.24, 2.0 ±0.21 and <1 a 20, 30, and 40 days o age,
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License
ABDOSHAH ET AL.1543
FIGURE 3 Hemagglu ina ion inhibi ion (HI) an ibody i es
agains Newcas le disease i us in speci ic pa hogen ee chickens
accina ed by he I-2 s ain (ND.TR.IR) a di e en ages. No e:
Chickens we e accina ed wi h a dose o ND.TR.IR (V1, V7, and V21)
o ecei ed dis illed wa e (C1,C
7,andC
21) h ough eye d op a 1, 7,
and 21 days o age. An ibody i es we e measu ed 21 days a e each
adminis a ion ime. Values wi h di e en supe sc ip s (a and b)
indica e a signi ican di e ence (p<0.05). E o ba =s anda d e o
o he mean
espec i ely. Mean HI an ibody i es in he B1+LaSo a and ND.TR.IR
g oups showed a g adually dec easing end be ween 10 and 20 days
o age; howe e , ollowing he boos e accina ion a day 20 o age,
he an ibody le els emained a a cons an le el ( anged be ween 4.1 ±
0.36 and 4.4 ±0.42). Resul s o he challenge es showed 95% p o ec-
ion in B1+LaSo a and ND.TR.IR g oups which was highe han 35% o
he con ol g oup (p<0.05; Table 2).
Mean HI an ibody i es agains NDV in b oile s inocula ed wi h
di e en ND accines a e ep esen ed in Figu e 5. The an ibody le -
els we e no di e en be ween B1+LaSo a and ND.TR.IR g oups o e
he expe imen al pe iod (p<0.05), bu hey had signi ican ly highe HI
an ibody i es compa ed o he con ol chickens (p<0.05). A se e e
dec easing end in MDA i es was no ed om i s (5.8 ±0.18) o
en h (1.7 ±0.22) days o he expe imen . Howe e , ollowing he
i s ND accina ion, he an ibody le els we e inc eased in B1+LaSo a
(4.30 ±0.45) and ND.TR.IR (4.90 ±0.27) g oups compa ed o he con-
ol chickens on day 20 o age (p<0.05). The ea e , he an ibodies
i e o B1+LaSo a and ND.TR.IR g oups showed a ela i ely cons an
end and each 4.8 ±0.41 and 4.7 ±0.42 on day 30, and 4.3 ±0.49 and
4.2 ±0.39 on day 40 o age, espec i ely. Resul s o he challenge es in
his expe imen showed ull p o ec ion (100%) in bo h B1+LaSo a and
ND.TR.IR accina ed chickens, while all he un accina ed challenged
chickens (con ol) died (Table 2).
4DISCUSSION
The welling o adminis a ion he mo esis an accines, especially in
illage condi ion, is inc easing du ing las decades. The I-2 is he main
ND s ain used o p oducing he mo esis an ND accines o u al
chickens. Howe e , i s po en ial use in eme gency accina ion and no
e idence o e e s o i ulence has also made i a candida e ac-
cine o con ol ND in comme cial locks (Bisschop e al., 2021). In an
a emp o p oduce a he mo esis an ND accine, in his s udy, an I-
2 o igina ed accinal seed was success ully cha ac e ized and i s e i-
cacy agains ND was in es iga ed in SPF, na i e, and b oile chickens.
Resul s o he p esen s udy e ealed a comple e iden i y be ween
genomic sequences o he s udied i us and I-2 s ain showing he
po en ial o he s udied i us as a accinal seed. Acco ding o W. H.
Allan e al. (1978), an a i ulen NDV complies wi h he IVPI, ICPI,
and MDT indices when hei co esponding alues a e ze o, less han
0.5, and longe han 90 h, espec i ely. Consis en wi h he molecula
FIGURE 4 E ec o adminis a ion a he mo esis an Newcas le disease (ND) accine (ND.TR.IR) e sus common accina ion p og amme (B1
and LaSo a) on an ibody i e agains ND in na i e chickens. No e: The chickens ecei ed a dose o ND.TR.IR o B1 and LaSo a ND accines a days
10 and 20 o age ia eye d op and d inking wa e , espec i ely. Values wi h di e en supe sc ip s (a and b) wi hin each sampling ime indica e a
signi ican di e ence (p<0.05). E o ba =s anda d e o o he mean
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License

1544 ABDOSHAH ET AL.
TABLE 2 P o ec ion le el o speci ic pa hogen- ee (SPF), na i e, and b oile chickens accina ed wi h common accina ion p og am (B1 and
LaSo a) o a he mo esis an Newcas le disease (ND) accine (ND.TR.IR) in he challenge wi h i ulen ND i us
Expe imen al g oups V1 V7 V21 Con ol (C1,C
7, and C21)
SPF1100% (10/10)a100% (10/10)a100% (10/10)a0% (0/10)b,2
Expe imen al g oups – B1+LaSo a ND.TR.IR Con ol
B oile 3– 100% (10/10)a100% (10/10)a0% (0/10)b
Na i e chicken3–95% (19/20)a95% (19/20)a35% (7/20)b
1Chickens in V1, V7, and V21 g oups we e accina ed wi h a dose o ND.TR.IR o ecei ed dis illed wa e (C1,C
7,andC
21) h ough eye d op a 1, 7, and 21 days
o age, espec i ely.
2Resul s o con ol g oups in C1, C7, and C21 we e he same.
3The chickens ecei ed B1 and LaSo a o ND.TR.IR accines a days 10 and 20 o age ia eye d op and d inking wa e , espec i ely.
a,bWi hin each ow, alues wi h di e en supe sc ip s a e signi ican ly di e en (p<0.05).
FIGURE 5 E ec o adminis a ion a he mo esis an Newcas le disease (ND) accine (ND.TR.IR) e sus common accina ion p og am (B1
and LaSo a) on an ibody i e agains ND in b oile chickens. No e: The chickens ecei ed a dose o ND.TR.IR o B1 and LaSo a ND accines a days
10 and 20 o age ia eye d op and d inking wa e , espec i ely. Values wi h di e en supe sc ip s (a and b) wi hin each sampling ime indica e a
signi ican di e ence (p<0.05). E o ba =s anda d e o o he mean
iden i ica ion esul s, he ob ained alues o he pa hogenici y indices
app o ed ha he ND.TR.IR is a candida e accinal seed.
In he p esen s udy, h ee expe imen s we e conduc ed o e alu-
a e he e icacy o ND.TR.IR. Acco ding o he OIE (2012), he e icacy
e alua ion o a li e ND accine mus be conduc ed on 10 o mo e SPF
o o he ully suscep ible chickens, a he minimum ecommended age
using he minimum ecommended dose. Meanwhile, o ob ain mo e
conclusi e esul s, in he i s expe imen , he e icacy o he ND.TR.IR
accine was examined in di e en ages o chickens. Ou esul s showed
ha he inocula ion o 1-day-old SPF chickens wi h ND.TR.IR was asso-
cia ed wi h se a an ibody i es g ea e han 23, a 21 days pos -
accina ion. The highe an ibody i es which we e obse ed in he
chickens inocula ed a 7 and 21 days o age is explained by he de el-
oped immune sys em in he elde chickens (Ambali e al., 2017;Al-
Ga ib e al., 2003). The app op ia e se ological immune esponse in
chickens ecei ed ND.TR.IR was suppo ed by he esul o he chal-
lenge e icacy es , whe e he accina ed chickens we e ully p o ec ed
agains NDV in ec ion. I has been documen ed ha chickens wi h HI
an ibody i e s ≥23would be p o ec ed ollowing he challenge e i-
cacy es (W. Allan & Gough, 1974; Hossain e al., 2010; Hassanzadeh
e al., 2020; Van Bo en e al., 2008). Howe e , he e a e pieces o e i-
dence showing ha he chickens wi h lowe i e also may su i e a e
he challenge (Mee s & Sp adb ow, 2006). In addi ion o he ci cula ing
an ibody, cellula and mucosal immuni y a e also in ol ed in acqui ing
a good p o ec ion le el in a challenge wi h he i ulen i us; howe e ,
because o de e mina ion o ci cula ing an ibody is mo e easible and
easie , i is conside ed as he p ima y index o e alua ion p o ec ion
agains diseases.
In he second expe imen , he e icacy o ND.TR.IR on na i e
chickens was e alua ed and compa ed wi h a ou ine accina ion
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License
ABDOSHAH ET AL.1545
p og am. Resul s showed an app op ia e HI an ibody aise and p o-
ec ion agains NDV in all o he accina ed chickens. In ag eemen
wi h 95% p o ec ion eco ded in his expe imen , Ilonggo e al. (2008)
epo ed ha he mos able I-2 ND accine p o ided 100% and 89%
p o ec ion agains ND in-housed and unhoused chickens, espec i ely.
Mo eo e , in es iga ions on u al locks ha e e ealed ha I-2 o igi-
na ed accines we e associa ed wi h app oxima ely 80% co e age and
long- e m immuni y (Adwa and Lukeso a, 2008). His o ically, he -
mos able ND accines ha e been de eloped a he Queensland Uni-
e si y and used in se e al de eloping coun ies o con ol ND in u al
locks (Mee s & Sp adb ow, 2006); howe e , due o mo e s abili y in
ambien empe a u e and la e al ansmission, he he mos able ND
accines a e usually associa ed wi h a lowe a ia ion in an ibody i es
and cause be e p o ec ion agains ND (Alde s & Sp adb ow, 2001;
Illango e al., 2008; Shahid Mahmood e al., 2014). These ad an ages
ha e made he he mos able ND accine as a good op ion o he use in
comme cial b oile a ms.
Resul s o he hi d expe imen e icacy es showed ha immune
esponse de i ed om ND.TR.IR o ou ine ND accines (B1 and
LaSo a) was no di e en in he comme cial b oile s. Despi e he negli-
gible di e ence in se a an ibody i es, bo h immuniza ion p og ammes
we e associa ed wi h ull p o ec ion agains NDV. These indings we e
in line wi h he esul s o he second expe imen in na i e chickens.
Following accina ion, he immunized chickens acqui e humo al and
cellula as well as mucosal immuni y. Howe e , by he in amuscula
ou e o challenge, he NDV is bypassed h ough mucosal immuni y
ha is one o he i s de ensi e ba ie s agains pa hogens. The e-
o e, esis ance o challenge wi h he in amuscula ou e is ega ded
as he gold s anda d o e alua ing he e icacy o i al accines (Mee s
& Sp adb ow, 2006). I has been widely accep ed ha he d immu-
ni y p o ides some p o ec ion o subop imal o un accina ed chick-
ens (Hassanzadeh & Bozo gme i Fa d, 2004; Kapczynski e al., 2013)
i mo e han 85% o he chickens acqui e HI an ibody i es g ea e
han 23a e wo ND accina ions (Van Bo en e al., 2008). The cu -
en esul s we e co obo a ed by he p e ious s udies which epo ed
ha an ibody i e ≥23is he possible p o ec i e le el in chickens ac-
cina ed agains ND (W. Allan & Gough, 1974; Bensink & Sp adb ow,
1999; Wambu a, 2011). Meanwhile, Kapczynski and King (2005)sug-
ges ed ha a comme cial b oile housing, only chickens wi h HI i es
g ea e han 24su i ed in NDV challenge and 66% o chickens wi h
lowe an ibody i es emained as unp o ec ed. Mo e commonly, HI
i es ≥25a e ypically sugges ed as a p o ec i e le el (W. H. Allan
e al., 1978; Kapczynski e al., 2013). In his s udy, 100%, 80%, and
60% o he ND.TR.IR-inocula ed b oile chickens had HI an ibody i es
≥23,2
4,and2
5on day 30 o age, espec i ely (da a we e no shown).
Howe e , he ob ained an ibody i es we e associa ed wi h 100% p o-
ec ion agains NDV, unde a con olled examina ion. As he inci-
dence o ND in chicken locks usually occu ed a 4–5 weeks o age
(Hassanzadeh & Bozo gme i Fa d, 2004), he highe p opo ion o
chickens wi h p o ec i e i es would dec ease he mo bidi y and mo -
ali y a e in he ea ly ND challenge.
I is wo h no ing ha he a e age MDA i e was highe in il-
lage chickens compa ed o b oile s. P obably, lowe biosecu i y mea-
su es in na i e locks han he s ic condi ions obse ed in b oile
b eede s cause mo e expose wi h NDV, esul ing in a highe MDA
i e in hei o sp ing. In addi ion, he mo e apid dec easing end
in MDA i es o b oile s han ha o na i e chickens is explained by
he highe me abolic a e associa ed wi h gene ic selec ion o mo e
g ow h a e and weigh gain. In acco dance, Gha aibeh and Mahmoud
(2013) epo ed ha a ia ions in he MDA hal -li e may s em om ac-
o s ela ed o di e ences in chicken lines and ypes.
5CONCLUSION
In his s udy, a ecei ed I-2 o igina ed ND i us success ully complied
wi h he equi ed speci ica ions o a accinal seed. Also, adminis a ion
o he p oduced ND.TR.IR accine p ope ly aised HI an ibody i es
associa ed wi h a high p o ec ion le el agains NDV in SPF, na i e, and
b oile chickens. These indings sugges ha no only ND.TR.IR migh
be use ul o p e en ND ou b eaks in u al locks bu also i could be
ad ised o be adminis a ed in comme cial b oile s a ms. Howe e ,
u he s udies a e wa an ed.
ACKNOWLEDGEMENT
The au ho s would like o hank he Razi Vaccine and Se um Resea ch
Ins i u e o inancial suppo o his p ojec unde g an numbe 12-
18-18-036-95017-950501.
CONFLICT OF INTEREST
No po en ial con lic o in e es is epo ed by he au ho s.
ETHICS STATEMENT
The expe imen was conduc ed unde app o al gi en om Razi Vac-
cine and Se um Resea ch Ins i u e (RVSRI) E hics Commi ee, Ka aj,
I an.
AUTHOR CONTRIBUTIONS
Concep ualiza ion, me hodology, supe ision, and p ojec adminis a ion:
Mohammad Abdoshah and Mohammad Hassanzadeh. Visualiza ion,
in es iga ion, w i ing—o iginal d a , and w i ing— e iew and edi ing:
Shahin Masoudi and Abbas Ash a i. Fo mal analysis, isualiza ion,
w i ing—o iginal d a , and w i ing— e iew and edi ing: Ali Reza Youse i.
Me hodology and w i ing—o iginal d a : Minoo Pa o i Nas .
DATA AVAILABILITY STATEMENT
The da a ha suppo he indings o his s udy a e a ailable on eques
om he co esponding au ho .
PEER REVIEW
The pee e iew his o y o his a icle is a ailable a h ps://publons.
com/publon/10.1002/ ms3.794.
ORCID
Mohammad Abdoshah h ps://o cid.o g/0000-0001-5768-5686
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License
1546 ABDOSHAH ET AL.
REFERENCES
Adwa , T., & Lukeso a, D. (2008). E alua ion o he mos able accines
agains Newcas le disease in illage chicken used in opics and sub op-
ics. Jou nal o Ag icul u e and Ru al De elopmen in he T opics and Sub op-
ics,41(2),74–79.
Ahle s, C., Hü ne , K., & P ei e , D. (1999). Compa ison be ween a li e
and an inac i a ed accine agains Newcas le disease in illage chickens.
A ield s udy in no he n Malawi. T opical Animal Heal h and P oduc ion,
31(3), 167–174. h ps://doi.o g/10.1023/A:1005117613340
Al-Ga ib, S., Gielkens, A., G uys, E., & Kochi, G. (2003). Re iew o Newcas-
le disease i us wi h pa icula e e ences o immuni y and accina ion.
Wo ld’s Poul y Science Jou nal,59(2), 185–200. h ps://doi.o g/10.1079/
WPS20030011
Alde s, R., & Sp adb ow, P. (2001). In oduc ion o li e he mos able New-
cas le disease accines. InR. Alde s &P. Sp adb ow (Eds.), Con olling
Newcas le disease in illage chickens. A ield manual ( ol. 44, pp. 37–44).
Canbe a.
Alde s, R. G. (2014). Making Newcas le disease accines a ailable a il-
lage le el. Ve e ina y Reco d,174(20), 502–503. h ps://doi.o g/10.1136/
.g3209
Allan, W., & Gough, R. (1974). A s anda d haemagglu ina ion inhibi ion es
o Newcas le disease. (1). A compa ison o mac o and mic o me hods.
Ve e ina y Reco d,95(6), 120–123. h ps://doi.o g/10.1136/ .95.6.120
Allan, W. H., Lancas e , J. E., & To h, B. (1978). Newcas le disease ac-
cines, hei p oduc ion and use: Food and Ag icul u e O ganiza ion o he
Uni ed Na ions. h ps://ag is. ao.o g/ag is-sea ch/sea ch.do? eco dID=
XF2015002878
Ambali, H., Nwoha, R., & Abdu, P. (2017). E alua ion o an ibody esponse
o Newcas le disease accina ion in chickens in some comme cial a ms-
Ii wo local go e nmen a eas in Lagos S a e, Nige ia. Jou nal o Ve -
e ina y Medicine and Su ge y,1(2), 1–6. h ps://doi.o g/10.9734/AJEA/
2016/27456
Bensink, Z., & Sp adb ow, P. (1999). Newcas le disease i us s ain I2—A
p ospec i e he mos able accine o use in de eloping coun ies. Ve -
e ina y Mic obiology,68(1–2), 131–139. h ps://doi.o g/10.1016/S0378-
1135(99)00069-3
Bisschop, S. P., Pe e s, A., Domingue, G., Pea ce, M. C., Ve wey, J., & Poolman,
P. (2021). Newcas le disease accine i us I-2 ails o acqui e i ulence
du ing epea ed passage in i o. Ga es Open Resea ch,5, 76. h ps://doi.
o g/10.12688/ga esopen es.13212.2
Dias, P., Alde s, R., F inge, R., & Ma a, B. (2001). Labo a o y and ield i-
als wi h he mos able li e Newcas le disease accines in Mozambique.
P oceedings o an In e na ional Wo kshop.ACIAR P oceedings No. 103, 6–9
Ma ch, 2000, Mapu o, Mozambique.
Fen ie, T., Dadi, K., Kassa, T., Sahle, M., & Ca oli, G. (2014). E ec o accina-
ion on ansmission cha ac e is ics o highly i ulen Newcas le disease
i us in expe imen ally in ec ed chickens. A ian Pa hology,43(5), 420–
426. h ps://doi.o g/10.1080/03079457.2014.951832
F ozandeh-Moghadam, M., Madani, R., Dehghani, M., Mosa i, S.,
Pou bakhsh, S., & Golchin a , F. (2009). Cloning & exp ession o
p o ein gene (HR1 egion) o Newcas le disease i us NR43 iso-
la e om I an in E. coli.I anian Jou nal o Vi ology,3(3), 16–22.
h ps://doi.o g/10.21859/is .3.3.16
Gha aibeh, S., & Mahmoud, K. (2013). Decay o ma e nal an ibodies in
b oile chickens. Poul y Science,92(9), 2333–2336. h ps://doi.o g/10.
3382/ps.2013-03249
Hassanzadeh, M., Abdoshah, M., Youse i, A. R., & Masoudi, S. (2020). Com-
pa ison o he impac o di e en adminis a ion ou es on he e icacy o
a he mo esis an Newcas le disease accine in chickens. Vi al Immunol-
ogy,33(5), 361–366. h ps://doi.o g/10.1089/ im.2019.0125
Hassanzadeh, M., & Bozo gme i Fa d, M. (2004). A se ological s udy o New-
cas le disease in p e-and pos - accina ed illage chickens in no h o
I an. In e na ional Jou nal o Poul y Science,3(10), 658–661. h ps://doi.
o g/10.3923/ijps.2004.658.661
Hossain, K. M. M., Ali, M. Y., & Yama o, I. (2010). An ibody le els agains
Newcas le disease i us in chickens in Rajshahi and su ounding dis ic s
o Bangladesh. In e na ional Jou nal o Biology,2(2), 102–106. h ps://doi.
o g/10.5539/ijb. 2n2p102
Illango, J., Mukiibi-Muka, G., Abila, P., Musisi, G., & E oo i, A. (2008). The
alue o he Newcas le disease I-2 he mos able accine use in he u al
ee- ange poul y managemen sys em in Uganda. Li es ock Resea ch o
Ru al De elopmen ,20(9), 9–13.
Kapczynski, D. R., A onso, C. L., & Mille , P. J. (2013). Immune esponses
o poul y o Newcas le disease i us. De elopmen al and Compa a i e
Immunology,41(3), 447–453. h ps://doi.o g/10.1016/j.dci.2013.04.012
Kapczynski, D. R., & King, D. J. (2005). P o ec ion o chickens agains o e
clinical disease and de e mina ion o i al shedding ollowing accina-
ion wi h comme cially a ailable Newcas le disease i us accines upon
challenge wi h highly i ulen i us om he Cali o nia 2002 exo ic New-
cas le disease ou b eak. Vaccine,23(26), 3424–3433. h ps://doi.o g/10.
1016/j. accine.2005.01.140
Ka enbel , J., Mee s, J., & Gould, A. (2006). Genome sequence o he he -
mos able Newcas le disease i us (s ain I-2) e eals a possible pheno-
ypic locus. Ve e ina y Mic obiology,114(1–2), 134–141. h ps://doi.o g/
10.1016/j. e mic.2005.10.041
Lawal, J. R., El-Yuguda, A. D., & Ib ahim, U. I. (2016). E icacy o eed coa ed
Newcas le disease I2 accine in Village Chickens in Gombe S a e, Nige-
ia. Jou nal o Ve e ina y Science and Technology,7, 349. h ps://doi.o g/10.
4172/2157-7579.1000349
Mee s, J., & Sp adb ow, P. (2006). Assessing Newcas le disease accines o
use in illage locks. P oceedings o he 11 h In e na ional Symposium on
Ve e ina y Epidemiology and Economics, Cai ns, Aus alia.
Nasse , M., Loh , J., Meb a u, G., Zessin, K.-H., Baumann, M., & Ademe,
Z. (2000). O al Newcas le disease accina ion ials in E hiopia. A ian
Pa hology,29(1), 27–34. h ps://doi.o g/10.1080/03079450094243
OIE: Wo ld O ganisa ion o Animal Heal h. (2012). Manual o diagnos ic
es s and accines o e es ial animals.
Rex oad, J., Wie ho , C. M., Jones, L. S., & Middaugh, C. R. (2002). Lyophiliza-
ion and he he mos abili y o accines. Cell P ese a ion Technology,
1(2), 91–104. h ps://doi.o g/10.1089/153834402320882593
S a is ical Analysis Sys em. (2004). SAS Use ’s Guide S a is ics.Ca y,NC:SAS
Ins ., Inc.
Shahid Mahmood, M., Siddique, F., Hussain, I., Ahmad, S. I., & Ra ique,
A. (2014). The mos able accines o Newcas le disease: A e iew.
Wo ld’s Poul y Science Jou nal,70(4), 829–838. h ps://doi.o g/10.1017/
S0043933914000889
Shahid Yousa zai, A., & Liaqua -Ahmad, F. (2017). E ec Newcas le disease
on poul y due o high mo bidi y and mo ali y a es. Global Jou nal o
Poul y Fa ming and Vaccina ion,5(3), 362–367.
Van Bo en, M., Bouma, A., Fab i, T. H., Ka sma, E., Ha og, L., & Koch,
G. (2008). He d immuni y o Newcas le disease i us in poul y
by accina ion. A ian Pa hology,37(1), 1–5. h ps://doi.o g/10.1080/
03079450701772391
Wambu a, P. N. (2011). Fo mula ion o no el nano-encapsula ed Newcas le
disease accine able s o accina ion o illage chickens. T opical Animal
Heal h and P oduc ion,43(1), 165–169. h ps://doi.o g/10.1007/s11250-
010-9669-0
How o ci e his a icle: Abdoshah, M., Hassanzadeh, M.,
Masoudi, S., Ash a i, A., Youse i, A. R., & Pa o i Nas , M.
(2022). The mo esis an Newcas le disease accine e ec i ely
p o ec s SPF, na i e, and comme cial chickens in challenge
wi h i ulen i us. Ve e ina y Medicine and Science,8,
1539–1546. h ps://doi.o g/10.1002/ ms3.794
20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License